Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

The Clear Reason Why Stemline Therapeutics Inc. Skyrocketed as Much as 33%
The Clear Reason Why Stemline Therapeutics Inc. Skyrocketed as Much as 33%
Shares of Stemline Therapeutics (NASDAQ: STML), a small-cap clinical-stage biotechnology company with a focus on developing medicines to treat cancer, skyrocketed as much as 33% during Tuesday's....
Why Endo International plc Jumped and Then Faded -- Twice
Why Endo International plc Jumped and Then Faded -- Twice
Endo International (NASDAQ: ENDP) was up as much as 13.6% Tuesday before settling down to about half that gain after reporting preliminary third-quarter revenue and earnings results on Monday. The....
Why Novavax Stock Is Soaring Today
Why Novavax Stock Is Soaring Today
Shares of flu vaccine researcher Novavax (NASDAQ: NVAX) shot up 13.7% in early trading Tuesday after a positive analyst note out of Citigroup predicted "strong market opportunities" for the....
Why Adamas Pharmaceuticals Inc. Jumped Higher Today
Why Adamas Pharmaceuticals Inc. Jumped Higher Today
Adamas Pharmaceuticals (NASDAQ: ADMS) closed up 21% on Monday, after Point72 Asset Management disclosed in an SEC document on Friday after the bell that it boosted its stake in the drugmaker.The....
3 Reasons I've Been Aggressively Buying Intercept Pharmaceuticals
3 Reasons I've Been Aggressively Buying Intercept Pharmaceuticals
I admit it: I love trying to catch a falling knife. Sometimes you get sliced in the process, while at other times you leave vindicated by having gone against the grain. My belief is that small-cap....
Here's Why Endo International Stock Dropped as Much as 13.8% Today
Here's Why Endo International Stock Dropped as Much as 13.8% Today
Shares of generic pharma leader Endo International (NASDAQ: ENDP) sank nearly 14% today after the company announced two of its subsidiaries had filed a lawsuit against the U.S. Food and Drug....

	 
Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study
Quantum Genomics receives the Galien MedStartUp award for the innovative design of its NEW-HOPE study
Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company developing a new class of centrally-acting medication to treat hypertension and heart failure, announced....

	 
Quantum Genomics reçoit le prix Galien MedStartUp pour le design innovant de son étude NEW-HOPE
Quantum Genomics reçoit le prix Galien MedStartUp pour le design innovant de son étude NEW-HOPE
Quantum Genomics (Euronext Growth - FR0011648971 – ALQGC), société biopharmaceutique spécialisée dans le développement d'une nouvelle classe de médicaments agissant directement sur le cerveau....
Why Did Innoviva, Inc. Stock Fall Nearly 16% Wednesday?
Why Did Innoviva, Inc. Stock Fall Nearly 16% Wednesday?
Shares of bio-pharmaceutical company Innoviva (NASDAQ: INVA) fell as much as 17.4% on Wednesday. But the stock finished the trading day down 15.55%.The stock's decline came just before Innoviva....
This Marijuana Stock, With Its Eggs in 1 Basket, Popped 14% Last Week
This Marijuana Stock, With Its Eggs in 1 Basket, Popped 14% Last Week
When it comes to the markets' fastest growing industries, investors would have a hard time finding a group of stocks growing quicker than marijuana. According to a report from Marijuana Business....
1 Small-Cap Biotech Stock to Buy Right Now
1 Small-Cap Biotech Stock to Buy Right Now
Enzymes. You may not realize it, but they're pretty important to daily life. Your high-efficiency, phosphate-free laundry detergent that removes even the most stubborn stains in cold water? That's....
3 Small, Profitable Biotechs With Fantastic Growth
3 Small, Profitable Biotechs With Fantastic Growth
Investors could be forgiven for shying away from the stocks of small biotechs. Not only is the complex technology behind their products almost impossible for most of us to understand, the majority....
Is This $13 Billion Food Security Crisis Intrexon's Next Big Opportunity?
Is This $13 Billion Food Security Crisis Intrexon's Next Big Opportunity?
A few years ago, engineered biology conglomerate Intrexon (NYSE: XON) acquired a pioneering company called Oxitec. While there are plenty of whacky technology platforms in next-generation biotech,....
3 Stocks That Turned $3,000 Into $7,300 or More So Far in 2017
3 Stocks That Turned $3,000 Into $7,300 or More So Far in 2017
If you have just $3,000 to invest, that's a good foundation upon which to start building your portfolio. But resist the urge to bet it all on just one stock. Diversifying your holdings, even when....
3 Healthcare Stocks That Soared This Week: Are They Buys?
3 Healthcare Stocks That Soared This Week: Are They Buys?
It's stunning just how much healthcare stocks can move in only a matter of five days. For three healthcare stocks, the past week was especially fantastic thanks to major catalysts.TransEnterix....
Why Agenus Inc. Stock Slumped Today
Why Agenus Inc. Stock Slumped Today
Shares of the cancer immunotherapy and vaccine company Agenus (NASDAQ: AGEN) fell by as much as 16.7% on nearly five times the average volume today, before ultimately ending the day down by only....

	 
BOIRON : Activity in the third quarter of 2017
BOIRON : Activity in the third quarter of 2017
ACTIVITY IN THE THIRD QUARTER OF 2017 (Unaudited data) CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2017 in thousands of euros 2016 2017 Variation at current exchange....

	 
BOIRON : Activité du troisième trimestre 2017
BOIRON : Activité du troisième trimestre 2017
ACTIVITÉ DU TROISIÈME TRIMESTRE 2017 (Données non auditées) ACTIVITÉ CUMULÉE À FIN SEPTEMBRE 2017 en milliers d'euros 2016 2017 Var. taux courant 2017/2016 Var. taux constant....
Here's Why Corbus Pharmaceuticals Holdings Inc. Jumped Today
Here's Why Corbus Pharmaceuticals Holdings Inc. Jumped Today
In response to upbeat results released from a phase 2 clinical trial, shares of Corbus Pharmaceuticals (NASDAQ: CRBP), a clinical-stage biotech focused on inflammatory and fibrotic diseases,....
3 Reasons Cara Therapeutics Is a Better Growth Stock Than Novavax
3 Reasons Cara Therapeutics Is a Better Growth Stock Than Novavax
At one point this year, Cara Therapeutics (NASDAQ: CARA) stock was up more than 175%. Most of those gains were given up, though. The stock is now up a little over 30% year to date. But that's....
Why Spectrum Pharmaceuticals Stock Jumped Higher Today
Why Spectrum Pharmaceuticals Stock Jumped Higher Today
Spectrum Pharmaceuticals (NASDAQ: SPPI), a biotech developing treatments for various blood disorders and cancers, saw its shares gain as much as 51.7% today on over 19 times the average volume.....
Why Endocyte Is Rallying Today
Why Endocyte Is Rallying Today
Shares of Endocyte (NASDAQ: ECYT), a clinical-stage biotech focused on cancer, rose as much as 13% in early-morning trading on Tuesday on heavy volume. As of 11:35 p.m. EDT, the stock was up about....
Here's Why AVEO Pharmaceuticals Dropped as Much as 16.3% Today
Here's Why AVEO Pharmaceuticals Dropped as Much as 16.3% Today
Shares of surprise biopharma AVEO Pharmaceuticals (NASDAQ: AVEO) dropped over 16% today on nearly twice the daily average trading volume without any major news story breaking. What's going on?....
Why Impax Laboratories Inc Is Tanking Today
Why Impax Laboratories Inc Is Tanking Today
After confirming that it will be merging with a privately held drug manufacturer, shares of Impax Laboratories (NASDAQ: IPXL), a maker of generic and branded drugs, fell 10% as of 12:00 p.m. EDT....

	 
Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial
Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial
Press Release Paris & New York, 16 October 2017 Quantum Genomics nominated for the Galien MedStartUp Award for the innovative design of its NEW-HOPE trial Quantum Genomics....